93.5m COVID-19 Doses Administered To 65.5m Eligible Nigerians, NPHCDA Reveals 

AstraZeneca
AstraZeneca COVID-19 vaccine.

The National Primary Health Care Development Agency (NPHCDA) has revealed that, so far, 93.5 million doses of the COVID-19 vaccines have been administered to 65.5 million eligible Nigerians from March 2021 till date.

The executive director, NPHCDA, Dr. Faisal Shuaib made this known during a media interaction yesterday (November 13, 2022) in Abuja, saying this was based on the 2022 population estimates where only 46.3 million eligible Nigerians have not taken any of the COVID-19 vaccines.

The NPHCDA boss disclosed that Adamawa Sate has also joined the list of 12 states that have fully vaccinated over 50 per cent of their eligible population with the COVID-19 vaccines.

Also, he said that Johnson and Johnson COVID-19 vaccines, introduced in February 2022, accounted for 60 per cent of the current full vaccination coverage across the country.

He stated that the top five performing states on the COVID-19 mass vaccination campaign in the country were Nasarawa, Jigawa, Osun, Kaduna and Kano.

Shuaib said that Osun, Kaduna, Kebbi and Sokoto states have fully vaccinated at least half of their eligible population in the preceding 100 days of SCALES 3.0 implementation.

“The top 3 performing states in the last 100 days of SCALES 3.0 are Kaduna, Kano and Osun, with total vaccinations of 3.3, 2.8 and 2.5 million, respectively,” he explained.

He called on the 46.3 million Nigerians yet to be vaccinated to take advantage of the ongoing integrated vaccination campaign to get vaccinated against COVID-19.  

“They can visit the nearest vaccination site,” he advised. 

Shuaib said that the COVID-19 vaccine is free to all eligible Nigerians at all designated sites across the country, including the FCT. 

“Vaccination cards are also at no cost and are freely given to only those vaccinated at these sites,” he explained. 

Racheal Abujah
+ posts

Leave a Reply

get in touch

1,815FansLike
101FollowersFollow
47FollowersFollow

Latest News

Related Articles